Literature DB >> 15687148

Total hip arthroplasty with cement and without acetabular bone graft for severe hip dysplasia. A concise follow-up, at a minimum of twenty years, of a previous report.

A S Klapach1, J J Callaghan, K A Miller, D D Goetz, P M Sullivan, D R Pedersen, R C Johnston.   

Abstract

We previously evaluated a cohort of fifty-three patients with severe hip dysplasia (Crowe Type-II, III, or IV subluxation) who underwent a total of sixty-six Charnley total hip arthroplasties. The acetabular component was placed at the anatomic hip center, the superolateral defect was filled with cement, and no bone-grafting was used to supplement the acetabular wall. All but one patient, who was lost to follow-up, were followed until death or for a minimum of twenty years. Radiographic and functional follow-up data were collected prospectively. This retrospective review included twenty-four patients (thirty-four hips) who were alive at a minimum of twenty years following the surgery. Fourteen (22%) of the sixty-five hips underwent revision of a component, with eleven of the revisions performed because of aseptic loosening. Eight of those eleven hips underwent revision because of acetabular loosening alone; two, because of femoral loosening alone; and one, because of loosening of both components. The combined prevalence of revision because of aseptic loosening of the acetabular component and radiographic evidence of failure of the acetabular component was 28% (eighteen hips). With the numbers available, the need for acetabular revision was not associated with the percentage of cement coverage (p = 0.362) or the Crowe classification (p = 0.159). At a minimum of twenty years postoperatively, the survivorship of the acetabular component was 86% +/- 8% with revision because of aseptic loosening as the end point and 82% +/- 10% with revision because of aseptic loosening or radiographic evidence of loosening as the end point. The results that we evaluated at a minimum of twenty years after use of this technique can be compared with the results of other techniques in studies with similar long-term follow-up periods.

Entities:  

Mesh:

Year:  2005        PMID: 15687148     DOI: 10.2106/JBJS.D.02130

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  7 in total

1.  Reliability of the acetabular reconstruction technique using autogenous bone graft from resected femoral head in hip dysplasia: Influence of the change of hip joint center on clinical outcome.

Authors:  Joo Ho Song; Tae Soo Ahn; Pil Whan Yoon; Jae Suk Chang
Journal:  J Orthop       Date:  2017-08-01

2.  Total hip arthroplasty in developmental dysplasia of the hip: Review of anatomy, techniques and outcomes.

Authors:  Scott Yang; Quanjun Cui
Journal:  World J Orthop       Date:  2012-05-18

3.  CORR Insights®: Satisfying Results of Primary Hip Arthroplasty in Patients with Hip Dysplasia at a Mean Followup of 20 Years.

Authors:  Rémy S Nizard
Journal:  Clin Orthop Relat Res       Date:  2016-08-30       Impact factor: 4.176

4.  Long-term results of cementless anatomic total hip replacement in dysplastic hips.

Authors:  Matteo Bruzzone; Massimo La Russa; Giacomo Garzaro; Andrea Ferro; Paolo Rossi; Filippo Castoldi; Roberto Rossi
Journal:  Chir Organi Mov       Date:  2009-10-30

5.  Favorable survival of acetabular reconstruction with bone impaction grafting in dysplastic hips.

Authors:  Matthijs P Somford; Stefan B T Bolder; Jean W M Gardeniers; Tom J J H Slooff; B Willem Schreurs
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

6.  Small stem total hip arthroplasty in hypoplasia of the femur.

Authors:  F Harald R De Man; Daniel Haverkamp; Harm M Van der Vis; Philip P Besselaar; René K Marti
Journal:  Clin Orthop Relat Res       Date:  2008-03-15       Impact factor: 4.176

7.  Novel 3D printed integral customized acetabular prosthesis for anatomical rotation center restoration in hip arthroplasty for developmental dysplasia of the hip crowe type III: A Case Report.

Authors:  Heng Zhang; Yang Liu; Qirong Dong; Jianzhong Guan; Jiansheng Zhou
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.